Cognition Therapeutics Announces Participation in September Investment Conferences

September 6, 2022

https://www.globenewswire.com/news-release/2022/09/06/2510272/0/en/Cognition-Therapeutics-Announces-Participation-in-September-Investment-Conferences.html

PURCHASE, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq:CGTX) (the “Company” or “Cognition”), a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina, today announced that members of management will be participating in two investment conferences in September 2022.

Read more at globenewswire.com

Related news for (CGTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.